Pharma Journalist -

Valeo Pharma and Besins Healthcare announced a strategic agreement to commercialize Utrogestan (micronised natural progesterone; 200mg vaginal capsules) in Canada. Utrogestan is…
Read More...

Atomwise Inc. has entered into an evaluation agreement with Pfizer. Pfizer will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins…
Read More...

Roivant Sciences announced the launch of Respivant Sciences, a biopharmaceutical company focused on improving the lives of patients suffering from serious respiratory diseases.…
Read More...

Evotec AG and Almirall announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics through a novel approach to disrupt cell…
Read More...

Avista Pharma Solutions has announced upgrades to its Agawam, MA facility, increasing its analytical chemistry footprint while expanding its compendial and raw material testing…
Read More...

Halozyme Therapeutics announced that Roche has received approval from Health Canada for a subcutaneous (SC) formulation of trastuzumab (Herceptin SC) for the treatment of patients with…
Read More...

Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation for North American rights to Samumed's SM04646, being developed for the treatment of…
Read More...

CRISPR Therapeutics and ViaCyte announced a collaboration focused on the discovery, development, and commercialization of gene-edited allogeneic stem cell therapies for the treatment of…
Read More...

LEO Pharma A/S and MorphoSys AG announced an expansion of their existing strategic alliance to include peptide-derived therapeutics. The objective of the alliance is to identify novel,…
Read More...

SMi Group Reports: The official agenda and highlights for the 3rd annual conference, which is taking place on the 12th and 13th November 2018 in Iselin, New Jersey, has been released.…
Read More...